跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
朱 珍瑩
成員
,
臺北醫學大學癌症轉譯研究中心
助理研究員
,
CRISPR核心實驗室
https://orcid.org/0000-0003-1002-8640
電子郵件
cchu
tmu.edu
tw
h-index
1321
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2007
2025
每年研究成果
概覽
指紋
網路
專案
(4)
研究成果
(36)
資料集
(2)
類似的個人檔案
(6)
指紋
查看啟用 Cheng-Ying Chu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
ADAM9
15%
Aldo-Keto Reductase
15%
Androgen Receptor
16%
Arginine
30%
Argininosuccinate Synthetase 1
30%
Artemia
15%
Artemia franciscana
15%
Autophagy
51%
C-Terminus
22%
Cancer Cell
100%
Colon
15%
CRISPR/Cas9
17%
Drug Resistance
17%
Drug Therapy
15%
Endoderm
15%
Exon
17%
EZH2
15%
Flavonoid
15%
Gelatinase A
15%
Histamine N-Methyltransferase
15%
Homeostasis
18%
Interferon
15%
Interleukin-6
16%
Isoform
19%
Kinase
38%
Long Noncoding RNA
15%
Luteolin
18%
Messenger RNA
20%
Metabolic Pathway
20%
MicroRNA
15%
MMP2
15%
Mouse
25%
Nodal Signaling
15%
Oncogene C Myc
15%
Phosphotransferase
38%
Promoter Region
39%
Pyruvate Kinase
15%
Quercetin
18%
Repressor
15%
RNA
27%
Sf9
18%
STAT Protein
18%
STAT6
15%
Superoxide Dismutase
15%
Tetraodon
23%
Tetraodon nigroviridis
20%
Transactivation
19%
Transcription Factors
15%
Upregulation
24%
Zebra Fish
45%
Medicine and Dentistry
Aldo Keto Reductase
15%
Androgen
16%
Arginine
60%
Argininosuccinate Synthase
30%
Autophagy
36%
Biological Marker
20%
Bladder Cancer
15%
Bone Metastasis
15%
Breast Cancer
34%
Cancer Cell
90%
Cas9
17%
Cell Death
18%
cGAS-STING signaling pathway
15%
Cholangiocarcinoma
15%
Clinical Pathway
15%
Clustered Regularly Interspaced Short Palindromic Repeat
18%
Curcumin
15%
DNA Repair
15%
Drug Therapy
15%
Flavonoid
15%
Fusion Protein
16%
Gelatinase A
15%
Gene Expression
21%
Histamine
15%
Interferon
31%
Interferon Regulatory Factor 9
16%
Luteolin
18%
Malignant Neoplasm
23%
Manganese Superoxide Dismutase
15%
Metastatic Carcinoma
39%
Metastatic Colorectal Cancer
15%
Methyltransferase
15%
microRNA
15%
Neoplasm
31%
Oncogene C Myc
15%
Oxidative Phosphorylation
16%
Phosphotransferase
15%
Phosphotransferase Inhibitor
15%
Promoter Region
26%
Prostate Cancer
63%
Protein Tyrosine Kinase
15%
Quercetin
18%
Sodium Chloride
15%
Squamous Cell Carcinoma
15%
STAT2 Protein
15%
Thrombospondin 2
15%
Triple Negative Breast Cancer
16%
Tumor Progression
17%
Tumor Xenograft
15%
Upregulation
26%
Pharmacology, Toxicology and Pharmaceutical Science
Absence
8%
Aldo Keto Reductase
15%
Androgen
21%
Angiogenesis Inhibitor
15%
Arginine
45%
Argininosuccinate Synthase
15%
Bile Duct Carcinoma
15%
Bladder Cancer
15%
Blood Clotting Factor 9
15%
Bone Metastasis
15%
Cancer Growth
10%
Chitosan
45%
Complementary DNA
8%
Curcumin
15%
Drug Resistance
17%
Erythropoietin
30%
Fucoidan
15%
Fugu
10%
Fusion Protein
16%
Gelatinase A
15%
Globin
15%
Interferon
31%
Interferon Regulatory Factor 9
16%
Laminin
15%
Malignant Neoplasm
30%
Manganese Superoxide Dismutase
15%
Metastasis
15%
Metastatic Colorectal Cancer
15%
microRNA
15%
Mouse
20%
Nanoparticle
15%
Neoplasm
36%
Phosphotransferase
15%
Phosphotransferase Inhibitor
15%
Polyglutamic Acid
15%
Prostate Cancer
78%
Protein Tyrosine Kinase
15%
Quercetin
18%
Sodium Chloride
15%
Squamous Cell Carcinoma
15%
STAT2 Protein
15%
Teleost
26%
Tetraodon
10%
Tetraodon nigroviridis
15%
Thrombospondin 2
15%
Toxicology Evaluation
15%
Triple Negative Breast Cancer
15%
Tumor Growth
16%
Zebra Fish
63%
Zein
15%
